Status: Not yet recruiting
The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity
The goal of the PARTUM trial is to determine if taking low-dose aspirin daily for 6 weeks after delivery is similar (non-inferior) to usual care low-molecular-weight heparin injections to prevent venous thromboembolism (VTE: blood clots in the legs or lungs) for postpartum individuals with VTE risk factors.
Participants needed: 8,805
Trial details
Phase: Phase 3Age: 18+Biological sex: FemaleType: InterventionalSponsor: University of CalgaryUpdated: Mar 3, 2025Locations: 3
Eligibility criteria
Antepartum immobilization for ≥7 days. Immobilization is defined as bed rest wit... [+9]
More than 48 hours since delivery at the time of randomization [+11]